P1736: CHARACTERISTICS, HEALTHCARE UTILIZATION, AND COSTS ASSOCIATED WITH INOTUZUMAB OZOGAMICIN, BLINATUMOMAB, OR OTHER AGENTS FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE LYMPHO...

por Russell-Smith, A., Shah, R., Silverstein, A., Petrilla, A., Leinwand, B., Norris, D., Schroeder, A.
Publicado 2022